Mark Zimmerman was Appointed as Vice President at ViaCyte

Date of management change: April 15, 2016 

What Happened?

San Diego, CA-based ViaCyte Appointed Mark Zimmerman as Vice President

 

About the Company

ViaCyte is a privately held regenerative medicine company developing novel cell replacement therapies as potential long-term diabetes treatments to achieve glucose control targets and reduce the risk of hypoglycemia and diabetes-related complications. ViaCyte`s product candidates are based on directed differentiation of pluripotent stem cells into PEC-01 pancreatic islet progenitor cells, which are then implanted in durable and retrievable cell delivery devices. ViaCyte demonstrated that when effectively engrafted, PEC-01 cells can mature into glucose-responsive insulin producing cells in patients with type 1 diabetes. To accelerate and expand its efforts, ViaCyte has established collaborative partnerships with leading companies including CRISPR Therapeutics and W.L. Gore & Associates.

 

About the Person

Mark Zimmerman is Vice President at ViaCyte. Previously, Mark held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: McClure Katherine, Virtanen Markus, Jones Laura, Ganapathy Sri, Eaton Andrea, Senty Tom, Deng Tina, Lewis Edana, Wilson Antwan, Spruill Yancey, Lester Dailah

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.